Table 1.
Treatment | rhFSH n=11 | LH-rhFSH n=30 | HMG-rhFSH n=10 |
---|---|---|---|
Mean age (years) | 34.7±3.1 (29-39) | 38.1±3.2 (29-42) | 38.7±2.0 (34-41) |
Male factor | 5 | 3 | 2 |
Tubal factor | 1 | 10 | 1 |
Decreased ovarian reserve | 1 | 0 | 0 |
Mixed | 4 | 15 | 6 |
Idiopathic | 0 | 2 | 1 |
No of Oocytes retrieved | 6.9±3.8 (2-13) | 5.1±3.7 (0-18) | 5.4±2.9 (3-12) |
No of Oocytes MII | 4.7±2.2 (2-8) | 3.2±2.4 (0-12) | 2.9±2.2 (0-7) |
rhFSH: recombinant human FSH;
rhFSH: rhFSH along with recombinant LH;
rhFSH: rhFSH plus human menopausal gonadotrophin: MII: metaphase II oocytes